熱門詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
Novaliq
Novaliq是一家研究投藥的公司,宗旨是開(kāi)發(fā)創(chuàng)新藥物劑型。其專利半氟化烷烴(SFA)能夠用于各類給藥途徑,以便將藥物或氧氣運(yùn)送到需要治療的部位。依托其獨(dú)有的生理化學(xué)特性, Novaliq目前正在開(kāi)發(fā)眼科創(chuàng)新劑型以及器官保存解決方案,擁有若干市場(chǎng)前景卓著的候選產(chǎn)品,這些產(chǎn)品正處于不同的開(kāi)發(fā)階段。
Novaliq GmbH is a drug delivery company located in the Heidelberg Technology Park, Germany. They develop innovative pharmaceutical formulations based on semifluorinated alkanes (SFAs).
Their patented SFAs can be used in various routes of administration for the transport of drugs or oxygen for therapeutic purposes. Novaliq currently develops novel ophthalmic and dermatological products as well as solutions for organ preservation, based on the unique physicochemical properties of SFA.
Their first product on the market is I-Let Protect? an organ preservation liquid based on SFA.
Besides the development of its own products and licensing them to pharmaceutical distributors, Novaliq is offering its SFA technology as a delivery platform for external co-development cooperations.